Loading…
Based on limited metadata, this FDA Warning Letter issued to Reishi D. International, Inc. on February 6, 2018 concerns a company involved with products classified as "Other" by the FDA. Without access to the full letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is not identified in the metadata provided, which limits clarity on the specific regulatory pathway or product category involved. Additional documentation would be needed to understand the particular compliance issues that prompted this enforcement action.